SCHEMBL2201326

SCHEMBL2201326

O=C(Nc1ccccc1)c1ccc2cccnc2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 15/20 1.00
ALDH1A1 P00352 1/20 0.66
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
PRKCI P41743 1/20 0.55
MEN1 O00255 1/20 0.55
MAPT P10636 1/20 0.55
KMT2A Q03164 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965470 0.89 EGLN1 (0.79) EGLN1ALDH1A1MAPT
SCHEMBL7685082 0.88 EGLN1 (0.78) EGLN1ALDH1A1NPC1RAB9ACASP3
Hydrochloric Acid SCHEMBL7688566 0.88 EGLN1 (0.77) EGLN1ALDH1A1MAPT
SCHEMBL7689924 0.87 EGLN1 (0.76) EGLN1ALDH1A1NPC1RAB9ACASP3
Hydrochloric Acid SCHEMBL7691643 0.87 EGLN1 (0.76) EGLN1ALDH1A1NPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL7692185 0.87 EGLN1 (0.76) EGLN1ALDH1A1NPC1RAB9ACASP3
SCHEMBL7965469 0.86 EGLN1 (0.74) EGLN1ALDH1A1NPC1RAB9AMEN1
SCHEMBL16735665 0.85 EGLN1 (0.74) EGLN1ALDH1A1NPC1RAB9ACASP3
Hydrochloric Acid SCHEMBL7684636 0.85 EGLN1 (0.72) EGLN1ALDH1A1NPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL7689283 0.85 EGLN1 (0.72) EGLN1ALDH1A1NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105168213-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA 2015-12-23 CN claimed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US claimed
EP-2519503-B1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2013-10-23 EP claimed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US claimed
EP-2519503-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2012-11-07 EP claimed
CN-102712597-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives as antifungal agents POLICHEM SA 2012-10-03 CN claimed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP claimed
CN-105168213-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA 2015-12-23 CN disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
EP-2519503-B1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2013-10-23 EP disclosed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US disclosed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US disclosed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US disclosed
EP-2519503-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2012-11-07 EP disclosed
CN-102712597-A Secondary 8-hydroxyquinoline-7-carboxamide derivatives as antifungal agents POLICHEM SA 2012-10-03 CN disclosed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP disclosed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS ERG28, TUBA8, CYP51A1 EGLN1 1246/4885ALDH1A1 1232/4885NPC1 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.